Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Steris's peak revenue was $5.1B in 2023. The peak quarterly revenue was $1.4B in 2023(q4).
Steris's revenue increased from $1.9b in 2014 to $5.1B currently. That's a 177.73% change in annual revenue.
| Fiscal year / year | Steris revenue |
|---|---|
| 2014 | $1.9B |
| 2015 | $2.2B |
| 2016 | $2.6B |
| 2017 | $2.6B |
| 2018 | $2.8B |
| 2019 | $3.0B |
| 2020 | $3.1B |
| 2021 | $4.2B |
| 2022 | $4.5B |
| 2023 | $5.1B |
How accurately did Steris' revenue projections match actual performance?
Steris saw the greatest revenue growth in 2021, when revenue increased by 47.55%.
Steris had the lowest revenue growth in 2017, when revenue changed by 0.28%.
| Year | Steris growth |
|---|---|
| 2015 | 21%↑ |
| 2016 | 17%↑ |
| 2017 | 0%↑ |
| 2018 | 6%↑ |
| 2019 | 9%↑ |
| 2020 | 3%↑ |
| 2021 | 36%↑ |
| 2022 | 7%↑ |
| 2023 | 13%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2015 | - | - | $618.7M | $690.3M |
| 2016 | $638.4M | $646.4M | $646.8M | $681.2M |
| 2017 | $608.0M | $634.2M | $661.9M | $716.0M |
| 2018 | $638.8M | $679.0M | $696.2M | $768.2M |
| 2019 | $696.8M | $736.8M | $774.3M | $823.0M |
| 2020 | $668.9M | $756.1M | $808.9M | $873.5M |
| 2021 | $968.4M | $1.2B | $1.2B | $849.0M |
| 2022 | $1.2B | $1.2B | $1.2B | $963.3M |
| 2023 | $1.2B | $1.2B | $1.3B | $1.4B |
| 2024 | $1.3B | $1.3B | $1.4B | - |
Do you work at Steris?
Did Steris meet its revenue projections?
| CEO | Walter M Rosebrough Jr. |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 12,000 |
| Date Founded | 1985 |
| Headquarters | Mentor, Ohio |
| Number of Locations | 41 |
| Revenue | $5.1B |
| Net Income | $107,030,000 |
| Gross Proft | $2.2B (2023) |
| PE Ratio | 21.02 |
| Tax Rate | 0.2% |
| Market Capitalization | $8.0B |
| Total Assets | $10,821,839,000 |
| Ticker | STE |
Steris received early financing of $285.0K on 2010-05-21.
| Series | Round size | Date |
|---|---|---|
| Debt Financing - STERIS Corporation | $285K | 05/2010 |
Steris's top competitor, McKesson, earned an annual revenue of $309.0B.
Steris's smallest competitor is FSI with revenue of $8.5M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Stryker | $69,470 | $22.6B | 43,000 | 2,083 |
| Boston Scientific | $60,291 | $16.7B | 36,000 | 791 |
| McKesson | $51,976 | $309.0B | 80,000 | 500 |
| Johnson & Johnson | $76,686 | $88.8B | 134,500 | 2,041 |
| Cardinal Health | $48,123 | $226.8B | 48,000 | 6,891 |
| Danaher | $65,463 | $23.9B | 80,000 | 1,965 |
| Hospira | $64,435 | $4.5B | 19,000 | - |
| Express Scripts Holding | $40,382 | $100.1B | 26,600 | - |
| Visteon | $89,727 | $3.9B | 10,000 | - |
| CooperVision | $44,554 | $1.1B | 25 | 18 |
Zippia gives an in-depth look into the details of Steris, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Steris. The employee data is based on information from people who have self-reported their past or current employments at Steris. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Steris. The data presented on this page does not represent the view of Steris and its employees or that of Zippia.
Steris may also be known as or be related to STERIS Corporation, STERIS plc, Steris, Steris Corporation and Steris PLC.